INOVIO PHARMACEUTICALS, INC. (INO) › Shareholders' EquityINOVIO PHARMACEUTICALS, INC. (INO) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2010: $46.50M2011: $47.31M2012: $34.35M2013: $52.46M2014: $111.23M2015: $175.69M2016: $123.28M2017: $142.39M2018: $86.94M2019: $3.44M2020: $461.14M2021: $399.67M2022: $222.36M2023: $117.35M2024: $68.50M2025: $24.10M$24.10M2010Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$24.10M-64.8%2024$68.50M-41.6%2023$117.35M-47.2%2022$222.36M-44.4%2021$399.67M-13.3%2020$461.14M+13324.4%2019$3.44M-96.0%2018$86.94M-38.9%2017$142.39M+15.5%2016$123.28M-29.8%2015$175.69M+58.0%2014$111.23M+112.0%2013$52.46M+52.7%2012$34.35M-27.4%2011$47.31M+1.7%2010$46.50M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share